pubmed-article:6759168 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6759168 | lifeskim:mentions | umls-concept:C0030933 | lld:lifeskim |
pubmed-article:6759168 | lifeskim:mentions | umls-concept:C0072603 | lld:lifeskim |
pubmed-article:6759168 | lifeskim:mentions | umls-concept:C0066672 | lld:lifeskim |
pubmed-article:6759168 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:6759168 | pubmed:dateCreated | 1983-3-11 | lld:pubmed |
pubmed-article:6759168 | pubmed:abstractText | A spermine-dependent, polyphenylalanine-synthesizing cell-free system having an optimum activity at 75-85 degrees C, has been developed from the extremely thermoacidophilic archaebacterium Caldariella acidophila. The C. acidophila system is totally insensitive to the EF-Tu targeted antibiotics pulvomycin (at 40 degrees C) and kirromycin (at 47-72 degrees C) contrary to control systems derived from both mesophilic (Escherichia coli) and thermoacidophilic (Bacillus acidocaldarius) eubacteria. The archaebacterial EF-Tu-equivalent factor is also immunologically unrelated to eubacterial EF-Tu and does not cross react with antibodies against Escherichia coli EF-Tu. The pulvomycin and kirromycin reactions thus provide new phyletic markers for archaebacterial ancestry. | lld:pubmed |
pubmed-article:6759168 | pubmed:language | eng | lld:pubmed |
pubmed-article:6759168 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6759168 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6759168 | pubmed:month | Nov | lld:pubmed |
pubmed-article:6759168 | pubmed:issn | 0014-5793 | lld:pubmed |
pubmed-article:6759168 | pubmed:author | pubmed-author:GambacortaAA | lld:pubmed |
pubmed-article:6759168 | pubmed:author | pubmed-author:de RosaMM | lld:pubmed |
pubmed-article:6759168 | pubmed:author | pubmed-author:ChinaliGG | lld:pubmed |
pubmed-article:6759168 | pubmed:author | pubmed-author:NicolauxGG | lld:pubmed |
pubmed-article:6759168 | pubmed:author | pubmed-author:CammaranoPP | lld:pubmed |
pubmed-article:6759168 | pubmed:author | pubmed-author:LondeiPP | lld:pubmed |
pubmed-article:6759168 | pubmed:author | pubmed-author:TeichnerAA | lld:pubmed |
pubmed-article:6759168 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6759168 | pubmed:day | 8 | lld:pubmed |
pubmed-article:6759168 | pubmed:volume | 148 | lld:pubmed |
pubmed-article:6759168 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6759168 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6759168 | pubmed:pagination | 255-9 | lld:pubmed |
pubmed-article:6759168 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:meshHeading | pubmed-meshheading:6759168-... | lld:pubmed |
pubmed-article:6759168 | pubmed:year | 1982 | lld:pubmed |
pubmed-article:6759168 | pubmed:articleTitle | Archaebacterial elongation factor Tu insensitive to pulvomycin and kirromycin. | lld:pubmed |
pubmed-article:6759168 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6759168 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6759168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6759168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6759168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6759168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6759168 | lld:pubmed |